Axon Enterprise (AXON) Proxy filing summary
Event summary combining transcript, slides, and related documents.
Proxy filing summary
16 Apr, 2026Voting matters and shareholder proposals
Shareholders will vote on the election of nine directors as named in the proxy statement, with the board recommending a vote for each nominee.
An advisory vote will be held to approve the compensation of named executive officers.
Shareholders are asked to ratify the appointment of PricewaterhouseCoopers LLP as the independent registered public accounting firm for fiscal year 2026.
Board of directors and corporate governance
Nine director nominees are presented for election at the annual meeting.
Executive compensation and say-on-pay
An advisory vote is scheduled for shareholders to approve the compensation of named executive officers.
Partial view of Summaries dataset, powered by Quartr API
Latest events from Axon Enterprise
- Record growth, AI-driven innovation, and robust governance highlight this year's proxy agenda.AXON
Proxy filing16 Apr 2026 - 2025 revenue grew 33% to $2.8B, with record bookings and strong AI-driven product adoption.AXON
Q4 202510 Apr 2026 - AI-driven growth, cloud expansion, and new hardware fuel strong bookings and future targets.AXON
Morgan Stanley Technology, Media & Telecom Conference 20263 Mar 2026 - All board nominees and proposals were approved, with a focus on impact and future growth.AXON
AGM 20253 Feb 2026 - Q1 2025 revenue up 31% to $604M, margins and guidance raised, driven by software and innovation.AXON
Q1 20253 Feb 2026 - Q2 revenue up 35% to $504.1M, with raised outlook and strong recurring revenue growth.AXON
Q2 20242 Feb 2026 - Product innovation, recurring revenue, and new markets fuel strong growth and long-term outlook.AXON
Goldman Sachs Communacopia + Technology Conference20 Jan 2026 - Q3 revenue up 32% to $544M; full-year outlook raised on strong TASER, cloud, and AI demand.AXON
Q3 202415 Jan 2026 - 2024 revenue up 33% to $2.1B; 2025 guidance targets 25% growth and strong margins.AXON
Q4 20247 Jan 2026